112 related articles for article (PubMed ID: 4214361)
1. Transfer factor therapy in a patient with chronic vaginal candidiasis.
Grob PJ; Wüthrich B
J Obstet Gynaecol Br Commonw; 1974 Oct; 81(10):812-7. PubMed ID: 4214361
[No Abstract] [Full Text] [Related]
2. Transfer of cellular hypersensitivity in chronic mucocutaneous candidiasis monitored in vivo and in vitro.
Rocklin RE; Chilgren RA; Hong R; David JR
Cell Immunol; 1970 Sep; 1(3):290-9. PubMed ID: 5523582
[No Abstract] [Full Text] [Related]
3. Lymphocyte stimulation in Candida albicans infections.
Frisk A; von Stedingk LV; Wasserman J
Sabouraudia; 1974 Mar; 12(1):87-94. PubMed ID: 4210102
[No Abstract] [Full Text] [Related]
4. An immunologic study of vaginal candidiasis.
Tomsíková A; Tomaierová V; Kotál L; Novácková D
Int J Gynaecol Obstet; 1980; 18(6):398-403. PubMed ID: 6111474
[TBL] [Abstract][Full Text] [Related]
5. Anticandidal immunity and vaginitis: novel opportunities for immune intervention.
Cassone A; De Bernardis F; Santoni G
Infect Immun; 2007 Oct; 75(10):4675-86. PubMed ID: 17562759
[No Abstract] [Full Text] [Related]
6. Transfer factor in the treatment of a case of chronic mucocutaneous candidiasis.
Schulking ML; Adler WH; Altemeier WA; Ayoub EM
Cell Immunol; 1972 Apr; 3(4):606-15. PubMed ID: 4554089
[No Abstract] [Full Text] [Related]
7. Immunoglobulin classes of human serum antibodies in vaginal candidiasis.
Warnock DW; Milne JD; Fielding AM
Mycopathologia; 1978 Aug; 63(3):173-5. PubMed ID: 357978
[TBL] [Abstract][Full Text] [Related]
8. Systemic and mucosal immunization with Candida albicans hsp90 elicits hsp90-specific humoral response in vaginal mucosa which is further enhanced during experimental vaginal candidiasis.
Raska M; Belakova J; Horynova M; Krupka M; Novotny J; Sebestova M; Weigl E
Med Mycol; 2008 Aug; 46(5):411-20. PubMed ID: 18608941
[TBL] [Abstract][Full Text] [Related]
9. Some immunological properties of human cervical and vaginal secretions.
Govers J; Girard JP
Gynecol Invest; 1972; 3(5):184-94. PubMed ID: 4632685
[No Abstract] [Full Text] [Related]
10. [Antibody avidity in candidiasis patients].
Karaev ZO; Lebedeva TN; Mikhaĭlova NA; Mirzabalaeva AK
Zh Mikrobiol Epidemiol Immunobiol; 1992 Feb; (2):68-70. PubMed ID: 1279913
[TBL] [Abstract][Full Text] [Related]
11. Comparison of Candida-delayed hypersensitivity skin test size with lymphocyte transformation, migration inhibitory factor production and antibody titer.
Bice DE; Lopez M; Rothschild H; Salvaggio J
Int Arch Allergy Appl Immunol; 1974; 47(1):54-62. PubMed ID: 4603057
[No Abstract] [Full Text] [Related]
12. Immunological features in a case of chronic granulomatous candidiasis and its treatment with transfer factor.
Valdimarsson H; Wood CB; Hobbs JR; Holt PJ
Clin Exp Immunol; 1972 Jun; 11(2):151-63. PubMed ID: 4557179
[TBL] [Abstract][Full Text] [Related]
13. Mucocutaneous candidiasis, anergy and a plasma inhibitor of cellular immunity: reversal after amphotericin B therapy.
Paterson PY; Semo R; Blumenschein G; Swelstad J
Clin Exp Immunol; 1971 Nov; 9(5):595-602. PubMed ID: 4947556
[TBL] [Abstract][Full Text] [Related]
14. Detection of anti-Candida albicans IgE antibodies in vaginal washes from patients with acute vulvovaginal candidiasis.
Regúlez P; García Fernández JF; Moragues MD; Schneider J; Quindós G; Pontón J
Gynecol Obstet Invest; 1994; 37(2):110-4. PubMed ID: 8150365
[TBL] [Abstract][Full Text] [Related]
15. An outline of the role of anti-Candida antibodies within the context of passive immunization and protection from candidiasis.
Cassone A; De Bernardis F; Torososantucci A
Curr Mol Med; 2005 Jun; 5(4):377-82. PubMed ID: 15977993
[TBL] [Abstract][Full Text] [Related]
16. Transfer factor therapy in immuno-deficiencies.
Griscelli C; Revillard JP; Betuel H; Herzog C; Touraine JL
Biomedicine; 1973 May; 18(3):220-7. PubMed ID: 4742861
[No Abstract] [Full Text] [Related]
17. Cellular immunity in acquired candidiasis of the palate.
Budtz-Jörgensen E
Scand J Dent Res; 1973; 81(5):372-82. PubMed ID: 4587166
[No Abstract] [Full Text] [Related]
18. Defective mononuclear leukocyte chemotaxis: a previously unrecognized immune dysfunction. Studies in a patient with chronic mucocutaneous candidiasis.
Snyderman R; Altman LC; Frankel A; Blaese RM
Ann Intern Med; 1973 Apr; 78(4):509-13. PubMed ID: 4571566
[No Abstract] [Full Text] [Related]
19. Rats clearing a vaginal infection by Candida albicans acquire specific, antibody-mediated resistance to vaginal reinfection.
Cassone A; Boccanera M; Adriani D; Santoni G; De Bernardis F
Infect Immun; 1995 Jul; 63(7):2619-24. PubMed ID: 7790077
[TBL] [Abstract][Full Text] [Related]
20. Intravaginal immunization of humans with Candida albicans.
Waldman RH; Cruz JM; Rowe DS
J Immunol; 1972 Oct; 109(4):662-4. PubMed ID: 4627506
[No Abstract] [Full Text] [Related]
[Next] [New Search]
